Terms: = Prostate cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Diagnosis
165 results:
1. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
2. Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system.
Bennett R; Li EV; Ho AY; Aguiar JA; Neill C; Rowe SP; Patel HD; Savas H; Ross AE
Prostate; 2024 Jun; 84(8):717-722. PubMed ID: 38450787
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative Factors for Lymphovascular Invasion in prostate cancer: A Systematic Review and Meta-Analysis.
Karwacki J; Stodolak M; Nowak Ł; Kiełb P; Krajewski W; Lemiński A; Szydełko T; Małkiewicz B
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255928
[TBL] [Abstract] [Full Text] [Related]
4. Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapy.
Ozawa Y; Nohara S; Nakamura K; Hattori S; Yagi Y; Nishiyama T; Yorozu A; Monma T; Saito S
Prostate; 2024 Apr; 84(5):502-510. PubMed ID: 38173289
[TBL] [Abstract] [Full Text] [Related]
5. Role of psa levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy.
Santucci D; Vertulli D; Esperto F; Eolo Trodella L; Ramella S; Papalia R; Scarpa RM; de Felice C; Francesco Grasso R; Beomonte Zobel B; Faiella E
Actas Urol Esp (Engl Ed); 2024 Mar; 48(2):140-149. PubMed ID: 37981171
[TBL] [Abstract] [Full Text] [Related]
6. [miR-129 in the diagnosis, treatment and prediction of clinical prognosis of prostate cancer].
Zhao XD; Tang ZL; Wang ZH; Dong J; Xu S
Zhonghua Nan Ke Xue; 2022 Nov; 28(11):996-1005. PubMed ID: 37846115
[TBL] [Abstract] [Full Text] [Related]
7. The Prognostic Significance of Selected HLA Alleles on prostate cancer Outcome.
Stokidis S; Baxevanis CN; Fortis SP
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833904
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study.
Panagiotidis E; Fragkiadaki V; Papathanasiou N; Kypraios C; Liatsikos E; Klampatsas A; Paschali A; Exarhos D; Zarokosta F; Chatzipavlidou V; Apostolopoulos D; Datseris I
Nucl Med Commun; 2023 Dec; 44(12):1126-1134. PubMed ID: 37779440
[TBL] [Abstract] [Full Text] [Related]
9. Management of patients with localized prostate cancer and biochemical recurrence in Spain: A medical survey.
Correa R; Vidal N; Quesada-García A; Marcos R; Muñoz Del Toro J; Muñoz-Rodríguez J
Actas Urol Esp (Engl Ed); 2024 Apr; 48(3):218-227. PubMed ID: 37574011
[TBL] [Abstract] [Full Text] [Related]
10. Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis.
van Tuijl LA; Basten M; Pan KY; Vermeulen R; Portengen L; de Graeff A; Dekker J; Geerlings MI; Hoogendoorn A; Lamers F; Voogd AC; Abell J; Awadalla P; Beekman ATF; Bjerkeset O; Boyd A; Cui Y; Frank P; Galenkamp H; Garssen B; Hellingman S; Huisman M; Huss A; de Jong TR; Keats MR; Kok AAL; Krokstad S; van Leeuwen FE; Luik AI; Noisel N; Onland-Moret NC; Payette Y; Penninx BWJH; Rissanen I; Roest AM; Ruiter R; Schoevers RA; Soave D; Spaan M; Steptoe A; Stronks K; Sund ER; Sweeney E; Twait EL; Teyhan A; Verschuren WMM; van der Willik KD; Rosmalen JGM; Ranchor AV
Cancer; 2023 Oct; 129(20):3287-3299. PubMed ID: 37545248
[TBL] [Abstract] [Full Text] [Related]
11. Error mitigation enables PET radiomic cancer characterization on quantum computers.
Moradi S; Spielvogel C; Krajnc D; Brandner C; Hillmich S; Wille R; Traub-Weidinger T; Li X; Hacker M; Drexler W; Papp L
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3826-3837. PubMed ID: 37540237
[TBL] [Abstract] [Full Text] [Related]
12. The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis.
Kovač MB; Pavlin T; Čavka L; Ribnikar D; Spazzapan S; Templeton AJ; Šeruga B
J Geriatr Oncol; 2023 Sep; 14(7):101594. PubMed ID: 37482497
[TBL] [Abstract] [Full Text] [Related]
13. DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk prostate cancer Progression after Radical prostatectomy.
Pukl M; George M; Javanmardi A; Carraro A; Korbelik J; White R; MacAulay C; Palcic B; Keyes M; Volavšek M; Guillaud M
Urol J; 2024 Mar; 21(2):80-86. PubMed ID: 37481706
[TBL] [Abstract] [Full Text] [Related]
14. prostate cancer detection and segmentation on MRI using non-local mask R-CNN with histopathological ground truth.
Dai Z; Jambor I; Taimen P; Pantelic M; Elshaikh M; Dabaja A; Rogers C; Ettala O; Boström PJ; Aronen HJ; Merisaari H; Wen N
Med Phys; 2023 Dec; 50(12):7748-7763. PubMed ID: 37358061
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of prostate cancer biochemical recurrence by using discretization supports the critical contribution of the extra-cellular matrix genes.
Marin L; Casado F
Sci Rep; 2023 Jun; 13(1):10144. PubMed ID: 37349324
[TBL] [Abstract] [Full Text] [Related]
16. Diabetes and prostate cancer Outcomes in Men with Nonmetastatic Castration-Resistant prostate cancer: Results from the SEARCH Cohort.
Sergeyev A; Gu L; De Hoedt AM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen Z; Terris MK; Guerrios-Rivera L; Freedland SJ; Csizmadi I
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1208-1216. PubMed ID: 37294698
[TBL] [Abstract] [Full Text] [Related]
17. PSA density does not improve predictive accuracy of the UCSF-CAPRA score.
Parker R; Bell A; Chang K; Greenberg S; Washington SL; Cowan JE; Carroll PR; Cooperberg MR
Prostate; 2023 Jul; 83(10):922-928. PubMed ID: 37078628
[TBL] [Abstract] [Full Text] [Related]
18. An Australian experience using Tc-PSMA SPECT/CT in the primary diagnosis of prostate cancer and for staging at biochemical recurrence after local therapy.
Duncan I; Ingold N; Martinez-Marroquin E; Paterson C
Prostate; 2023 Jul; 83(10):970-979. PubMed ID: 37051636
[TBL] [Abstract] [Full Text] [Related]
19. Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.
Zhai T; Dou M; Ma Y; Wang H; Liu F; Zhang L; Chong T; Wang Z; Xue L
Lipids Health Dis; 2023 Mar; 22(1):39. PubMed ID: 36915125
[TBL] [Abstract] [Full Text] [Related]
20.
Haidar M; Abi-Ghanem AS; Moukaddam H; Jebai ME; Al Zakleet S; Al Rayess S; Akkawi AR; Kassas M; Tamim H; Hajj AE; Estrada-Lobato E; Osman MM; Shamseddine A
Sci Rep; 2022 Nov; 12(1):20500. PubMed ID: 36443430
[TBL] [Abstract] [Full Text] [Related]
[Next]
